数据链接：
官方服务：
资源简介：
RAS positive controls for LAG3, CTLA4 and TOX
应用场景：
创建时间：
2025-12-09
相关数据集
Targeting of the CD161 Inhibitory Receptor Enhances Bone Marrow-Resident Memory CD8+ T Cell-mediated Immunity Against Multiple Myeloma [Mice RNA-seq]
Immune checkpoint inhibitors (ICIs) have transformed the treatment of many solid tumors. Still, their effectiveness in multiple myeloma (MM) remains underwhelming, highlighting the need to explore alt
NIAID Data Ecosystem60
Additional file 5: Table S4. of Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
CT genes. (XLSX 60 kb)
Figshare2016-12-14 更新40
DataSheet_2_Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma.zip
IntroductionProstate adenocarcinoma (PRAD) is a highly aggressive malignancy with high mortality and poor prognosis, and its potential mechanism remains unclear. Our study aimed to identify novel mark
NIAID Data Ecosystem20
The Siglec-sialic acid-axis is a target for innate immunotherapy of glioblastoma
Recently, ‘don’t eat me’-signals like CD47 have emerged as novel innate immune checkpoints, enabling cancer cells to evade clearance by phagocytes such as microglia (MG) or monocyte-derived cells (MdC
NIAID Data Ecosystem50
PDB: 4ZQK, PD-1 and its ligand PD-L1 (310K, 37°C, 200 ns): random seed #3
4ZQK: PD-1 in complex with its ligand PD-L1 (310K, 37°C, 200 ns): random seed #3. PDBs taken every 50 ns.
DataONE2025-11-26 更新30
